Cite
Lefèvre B, Hoen B, Goehringer F, et al. Antistaphylococcal penicillins vs. cefazolin in the treatment of methicillin-susceptible Staphylococcus aureus infective endocarditis: a quasi-experimental monocentre study. Eur J Clin Microbiol Infect Dis. 2021;40(12):2605-2616doi: 10.1007/s10096-021-04313-3.
Lefèvre, B., Hoen, B., Goehringer, F., Sime, W. N., Aissa, N., Alauzet, C., Jeanmaire, E., Hénard, S., Filippetti, L., Selton-Suty, C., Agrinier, N. (2021). Antistaphylococcal penicillins vs. cefazolin in the treatment of methicillin-susceptible Staphylococcus aureus infective endocarditis: a quasi-experimental monocentre study. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 40(12), 2605-2616. https://doi.org/10.1007/s10096-021-04313-3
Lefèvre, B, et al. "Antistaphylococcal penicillins vs. cefazolin in the treatment of methicillin-susceptible Staphylococcus aureus infective endocarditis: a quasi-experimental monocentre study." European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology vol. 40,12 (2021): 2605-2616. doi: https://doi.org/10.1007/s10096-021-04313-3
Lefèvre B, Hoen B, Goehringer F, Sime WN, Aissa N, Alauzet C, Jeanmaire E, Hénard S, Filippetti L, Selton-Suty C, Agrinier N. Antistaphylococcal penicillins vs. cefazolin in the treatment of methicillin-susceptible Staphylococcus aureus infective endocarditis: a quasi-experimental monocentre study. Eur J Clin Microbiol Infect Dis. 2021 Dec;40(12):2605-2616. doi: 10.1007/s10096-021-04313-3. Epub 2021 Aug 12. PMID: 34383175.
Copy
Download .nbib